Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Banco Santander SA — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Banco Santander SA trades at $13.59 (market cap $196.43B). The key difference: Banco Santander SA is far larger — about 201× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Banco Santander SA pays a 2.16% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Banco Santander SA for 55 Days on average.
| MRVI | SAN | |
|---|---|---|
Market Cap | $977.37M | $196.43B |
Volume | 2,742,564 | 9,190,091 |
Sector | Health | Financials |
52-Week High | $9.00 | $15.05 |
52-Week Low | $2.83 | $9.65 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $1.08B | $360.59B |
Dividend Yield | — | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Banco Santander (SAN) trades at $13.55, up 0.52% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong profitability with 26.25% net income margin and 16.07% ROE, though recent earnings show volatility with one beat and two misses in the last four quarters. Recent developments include the completion of Webster Financial acquisition, expanding U.S. presence and diversification.
SAN presents a compelling value case with reasonable P/E of 13.68 and strong analyst support (64% buy ratings), but faces headwinds from declining cash flows and high debt levels. The stock offers income potential with upcoming $0.14 dividend, though investors should monitor the sustainability of recent profit margins amid operational cash flow challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
